Approval · Notice of Compliance 38448 · 2026
RAMIPRIL CAPSULES: Notice of Compliance 38448
Issued October 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38448
- Date
- October 9, 2026
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- ALTACE (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAMIPRIL CAPSULES | 02572478 | — |
Medicinal ingredients
- RAMIPRIL 2.5 MG per CAP